Former Food and Drug Administration (FDA) Commissioner, Dr Scott Gottlieb, has proposed ad hoc CBD regulations for the American market.
The UK's drug advisory board, the National Institute for Health and Care Excellence (NICE), this week released guidance for healthcare
The National Institute for Health and Care Excellence (NICE) has published research recommendations for Cannabis-based medicinal products for medicinal use
Reaction | Medical cannabis advocates disappointed with NICE guidelines, which approved two cannabis-based medicines available on the NHS
Pro-medical cannabis campaigners have voiced concerns at the new guidelines issued by the National Institute for Health and Care Excellence.
News | Landmark day for patients in the UK as two cannabis-based medicines have been approved for NHS prescription
Two cannabis-based medicines, Sativex and Epidyolex, which are used for conditions such as epilepsy and Multiple Sclerosis, have been approved